Ergomed (ERGO)

 

Latest News

Ergomed net service revenues up 53%

Ergomed's first half net service revenues rose by 53% to 19.5m and total revenues were up 31% at 22.9m. Gross profit rose b...

Interim Results

RNS Number: 9653Q Ergomed plc 18 September 2017 PRESS RELEASE Unaudited Interim results for the six months ended 30 June 2017 Strong first half financial performance - net service revenues up 53 % and gross profit up 42% Haemostatix programmes significantly advanced, PeproStat Phase IIb study ahead of schedule London, UK - 18 September 2017: Ergom...

CEL-SCI Corporation issues restricted shares

RNS Number: 5035O Ergomed plc 21 August 2017 PRESS RELEASE FOR IMMEDIATE RELEASE CEL-SCI Corporation issues restricted shares to Ergomed for partial settlement of receivable London, UK - 21 August 2017: Ergomed plc (LSE: ERGO) ('Ergomed' or the 'Company'), a company dedicated to the provision of specialised services to the pharmaceutical indu...

Ergomed's partner to resume Phase 3 study of Multikine

Ergomed said it has noted that its co-development partner CEL-SCI has confirmed the US Food and Drug Administration ...

All News

DateHeadlineSource
18-09-17Ergomed net service revenues up 53%StockMarketWire
18-09-17Interim ResultsRNS
21-08-17CEL-SCI Corporation issues restricted sharesRNS
14-08-17Ergomed's partner to resume Phase 3 study of MultikineStockMarketWire
14-08-17FDA removal of hold on Ph3 trial with MultikineRNS
14-08-17Ergomed schedules interim results StockMarketWire
14-08-17Notice of ResultsRNS
24-07-17Ergomed completes study recruitment ahead of schedule StockMarketWire
24-07-17Recruitment complete early for Phase IIb studyRNS
04-07-17Investor MeetingRNS
21-06-17PeproStat study passes recruitment mid-pointRNS
19-06-17Ergomed resolutions passed at AGMStockMarketWire
16-06-17Result of AGMRNS
16-06-17Ergomed appoints CEOStockMarketWire
16-06-17Appointment of CEORNS
13-06-17Ergomed to present at the Shares Spotlight Evening in Manchester on 29 June 2017StockMarketWire
22-05-17Appointment of N+1 Singer as joint brokerRNS
12-05-17Annual Report and Notice of AGMRNS
08-05-17Ergomed updates in PharmInvent earn-outStockMarketWire
08-05-17Issue of Shares to Former PharmInvent ShareholdersRNS
02-05-17Broker Forecast - Stifel issues a broker note on Ergomed PlcStockMarketWire
02-05-17Broker Forecast - Numis issues a broker note on Ergomed PlcStockMarketWire
02-05-17Co-Development Partner NewsRNS
26-04-1711 shares where positive earnings shocks could trigger ralliesInteractive Investor
13-04-17Board and Management ChangesRNS
04-04-17Director Deals - Ergomed Plc (ERGO)StockMarketWire
04-04-17Director/PDMR ShareholdingRNS
03-04-17Ergomed partner announces successful dataStockMarketWire
03-04-17Partner Asarina Pharma announces successful dataRNS
28-03-17Ergomed revenues up 30%StockMarketWire
28-03-17Ergomed revenues up StockMarketWire
28-03-17Unaudited Preliminary Results for 2016RNS
21-03-17Notice of Preliminary ResultsRNS
20-03-17Ergomed initiates study of PeprostatStockMarketWire
20-03-17Initiates Phase II Study of Topical PeproStatRNS
20-02-17Ergomed notes partner's successful financing roundStockMarketWire
20-02-17Modus Therapeutics Raises SEK 32 MillionRNS
06-02-17Broker Forecast - Numis issues a broker note on Ergomed PlcStockMarketWire
06-02-17Broker Forecast - Stifel issues a broker note on Ergomed PlcStockMarketWire
06-02-17Positive Phase II top-line results of LorediplonRNS

RSS feeds

  • Editorial news feed for LSE:ERGO Editorial
  • Regulatory news feed for LSE:ERGO Regulatory